Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1363283
PUBLISHER: Grand View Research | PRODUCT CODE: 1363283
Europe Blood Screening Market Size, Share & Trends Analysis Report By Product (Reagent, Instrument), By Technology (Nucleic Acid Amplification Test, ELISA, Next Generation Sequencing), By Region, And Segment Forecasts, 2023 - 2030
PUBLISHED:
PAGES: 64 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Europe Blood Screening Market Growth & Trends:
The Europe blood screening market size is expected to reach USD 1,954.8 million by 2030, registering a CAGR of 11.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increasing number of blood transfusion processes performed along with stringent regulations in Europe mandating screening tests, such as NAT for testing HIV, HBV, and HCV, is contributing to the market growth.
Moreover, growth in the overall number of complex surgeries that require a large amount of blood and blood products along with rising cases of road accidents is expected to drive the market further. Additionally, import of products through contract agreements and development in the product technology by manufacturers of blood screening reagents and instruments are contributing to market expansion in the region.
For example, DiaSystem Scandinavia AB signed a distribution agreement with SNIBE, an Asian immunology test producer that focuses on immunoassay analyzers based on CLIA technology. DiaSystem specializes in the production and supply of reagents used in chemistry and immunoturbidimetry. This agreement has provided the former company with automated chemiluminescence instrument delivering a complete analytical system in areas, such as thyroid, renal function, hepatitis, and hepatic fibrosis.
Europe Blood Screening Market Report Highlights:
- NAAT led the technology segment in 2022 owing to a regulatory obligation for mandatory NAAT screening for all blood donations.
- On the basis of product, reagents led the Europe blood screening market in 2022
- Germany held a majority of the market share in 2022 due to large number of blood donors.
- Moreover, stringent regulations in the country for screening of donations also contributed to its growth. The Paul-Ehrlich-Institut, a medical regulatory body in Germany, mandates NAT testing for HCV and HIV for all blood donations.
Product Code: GVR-2-68038-711-7
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Technology
- 1.1.3. Regional scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Technology outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Europe Blood Screening Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.4. Europe Blood Screening Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's Five Forces
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic Landscape
- 3.4.1. Industry Analysis - Porter's Five Forces
Chapter 4. Europe Blood Screening: Product Estimates & Trend Analysis
- 4.1. Europe Blood Screening Market: Key Takeaways
- 4.2. Europe Blood Screening Market: Product Movement & Market Share Analysis, 2022 & 2030
- 4.3. Reagent
- 4.3.1. Reagent Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 4.4. Instrument
- 4.4.1. Instrument Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 5. Europe Blood Screening Market: Technology Estimates & Trend Analysis
- 5.1. Europe Blood Screening Market: Key Takeaways
- 5.2. Europe Blood Screening Market: Technology Movement & Market Share Analysis, 2022 & 2030
- 5.3. Nucleic Acid Amplification Test
- 5.3.1. Nucleic Acid Amplification Test Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 5.4. ELISA
- 5.4.1. ELISA Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 5.5. Chemiluminescence Immunoassay
- 5.5.1. Chemiluminescence Immunoassay Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 5.6. Next-Generation Sequencing
- 5.6.1. Next Generation Sequencing Market Estimates and Forecasts, 2018 to 2030 (USD Million)
- 5.7. Western Blotting
- 5.7.1. Western Blotting Market Estimates and Forecasts, 2018 to 2030 (USD Million)
Chapter 6. Europe Blood Screening Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Europe Blood Screening Market by Region: Key Takeaways
- 6.3. Europe
- 6.3.1. UK
- 6.3.1.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. Germany
- 6.3.2.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. France
- 6.3.3.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.4. Italy
- 6.3.4.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.5. Spain
- 6.3.5.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.6. Denmark
- 6.3.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.7. Sweden
- 6.3.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.8. Norway
- 6.3.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.1. UK
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.2.1. Danaher Corporation
- 7.2.1.1. Company Overview
- 7.2.1.2. Financial Performance
- 7.2.1.3. Product Benchmarking
- 7.2.1.4. Strategic Initiatives
- 7.2.2. Beckman Coulter, Inc.
- 7.2.2.1. Company Overview
- 7.2.2.2. Financial Performance
- 7.2.2.3. Product Benchmarking
- 7.2.2.4. Strategic Initiatives
- 7.2.3. Abbott Laboratories
- 7.2.3.1. Company Overview
- 7.2.3.2. Financial Performance
- 7.2.3.3. Product Benchmarking
- 7.2.3.4. Strategic Initiatives
- 7.2.4. Thermo Fisher Scientific, Inc.
- 7.2.4.1. Company Overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Becton, Dickinson and Company
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic Initiatives
- 7.2.6. Grifols
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Ortho Clinical Diagnostics
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. F. Hoffmann-La Roche Ltd.
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Bio-Rad Laboratories, Inc.
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Siemens AG
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives
- 7.2.1. Danaher Corporation
Product Code: GVR-2-68038-711-7
List of Tables
- Table 1 List of Abbreviations
- Table 2 Europe blood screening market, by product, 2018 - 2030 (USD Million)
- Table 3 Europe blood screening market, by technology, 2018 - 2030 (USD Million)
- Table 4 Europe blood screening market, by region, 2018 - 2030 (USD Million)
- Table 5 Germany blood screening market, by product, 2018 - 2030 (USD Million)
- Table 6 Germany blood screening market, by technology, 2018 - 2030 (USD Million)
- Table 7 UK blood screening market, by product, 2018 - 2030 (USD Million)
- Table 8 UK blood screening market, by technology, 2018 - 2030 (USD Million)
- Table 9 France blood screening market, by product, 2018 - 2030 (USD Million)
- Table 10 France blood screening market, by technology, 2018 - 2030 (USD Million)
- Table 11 Italy blood screening market, by product, 2018 - 2030 (USD Million)
- Table 12 Italy blood screening market, by technology, 2018 - 2030 (USD Million)
- Table 13 Spain blood screening market, by product, 2018 - 2030 (USD Million)
- Table 14 Spain blood screening market, by technology, 2018 - 2030 (USD Million)
- Table 15 Denmark blood screening market, by product, 2018 - 2030 (USD Million)
- Table 16 Denmark blood screening market, by technology, 2018 - 2030 (USD Million)
- Table 17 Sweden blood screening market, by product, 2018 - 2030 (USD Million)
- Table 18 Sweden blood screening market, by technology, 2018 - 2030 (USD Million)
- Table 19 Norway blood screening market, by product, 2018 - 2030 (USD Million)
- Table 20 Norway blood screening market, by technology, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Data triangulation techniques
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value-chain-based sizing & forecasting
- Fig. 6 QFD modeling for market share assessment
- Fig. 7 Market formulation & validation
- Fig. 8 Europe blood screening: Market outlook
- Fig. 9 Europe blood screening competitive insights
- Fig. 10 Parent market outlook
- Fig. 11 Related/ancillary market outlook
- Fig. 12 Penetration and growth prospect mapping
- Fig. 13 Industry value chain analysis
- Fig. 14 Europe blood screening market driver impact
- Fig. 15 Europe blood screening market restraint impact
- Fig. 16 Europe blood screening market strategic initiatives analysis
- Fig. 17 Europe blood screening market: Product movement analysis
- Fig. 18 Europe blood screening market: Product outlook and key takeaways
- Fig. 19 Reagent market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 20 Instrument market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 21 Europe blood screening market: Technology movement analysis
- Fig. 22 Europe blood screening market: Technology outlook and key takeaways
- Fig. 23 Nucleic acid amplification test market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 24 ELISA market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 25 Chemiluminescence Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 26 Next generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 27 Western blotting market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 34 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 35 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 36 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.